Lamdong Pharmaceutical JSC (HNX:LDP)

Revenue by Segment

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Others	2.80B	2.41B	2.50B	-	-
Others Growth	16.39%	-3.50%	-	-	-
Manufacture	160.14B	129.91B	98.08B	-	-
Manufacture Growth	23.27%	32.46%	-	-	-
Trading	80.97B	85.64B	85.43B	-	-
Trading Growth	-5.46%	0.25%	-	-	-
Total	243.91B	217.96B	186.00B	-	-
Total Growth	11.91%	17.18%	-	-	-

Revenue by Geography

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Vietnam	243.91B	217.96B	186.00B	187.41B	161.90B
Vietnam Growth	11.91%	17.18%	-0.75%	15.76%	-57.36%
Total	243.91B	217.96B	186.00B	187.41B	161.90B
Total Growth	11.91%	17.18%	-0.75%	15.76%	-57.36%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 29, 2026

Data Sources Report a data error